H-DL-Leu-DL-Gln-Gly-DL-Ala-DL-Ser-DL-Leu-DL-Lys-OH
Internal ID | 872e73cd-8411-4733-9ec6-f27b28a265fe |
Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
IUPAC Name | 6-amino-2-[[2-[[2-[2-[[2-[[5-amino-2-[(2-amino-4-methylpentanoyl)amino]-5-oxopentanoyl]amino]acetyl]amino]propanoylamino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid |
SMILES (Canonical) | CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)N |
SMILES (Isomeric) | CC(C)CC(C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)N |
InChI | InChI=1S/C31H57N9O10/c1-16(2)12-19(33)27(45)37-20(9-10-24(34)42)28(46)35-14-25(43)36-18(5)26(44)40-23(15-41)30(48)39-22(13-17(3)4)29(47)38-21(31(49)50)8-6-7-11-32/h16-23,41H,6-15,32-33H2,1-5H3,(H2,34,42)(H,35,46)(H,36,43)(H,37,45)(H,38,47)(H,39,48)(H,40,44)(H,49,50) |
InChI Key | CVSCJYUBLBELRX-UHFFFAOYSA-N |
Popularity | 0 references in papers |
Molecular Formula | C31H57N9O10 |
Molecular Weight | 715.80 g/mol |
Exact Mass | 715.42283905 g/mol |
Topological Polar Surface Area (TPSA) | 327.00 Ų |
XlogP | -4.70 |
Atomic LogP (AlogP) | -3.56 |
H-Bond Acceptor | 11 |
H-Bond Donor | 11 |
Rotatable Bonds | 25 |
There are no found synonyms. |
![2D Structure of H-DL-Leu-DL-Gln-Gly-DL-Ala-DL-Ser-DL-Leu-DL-Lys-OH 2D Structure of H-DL-Leu-DL-Gln-Gly-DL-Ala-DL-Ser-DL-Leu-DL-Lys-OH](https://plantaedb.com/storage/docs/compounds/2023/11/h-dl-leu-dl-gln-gly-dl-ala-dl-ser-dl-leu-dl-lys-oh.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | - | 0.5476 | 54.76% |
Caco-2 | - | 0.8634 | 86.34% |
Blood Brain Barrier | + | 0.5500 | 55.00% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Mitochondria | 0.5364 | 53.64% |
OATP2B1 inhibitior | + | 0.5678 | 56.78% |
OATP1B1 inhibitior | + | 0.9032 | 90.32% |
OATP1B3 inhibitior | + | 0.9303 | 93.03% |
MATE1 inhibitior | - | 0.9600 | 96.00% |
OCT2 inhibitior | - | 0.9250 | 92.50% |
BSEP inhibitior | + | 0.8151 | 81.51% |
P-glycoprotein inhibitior | + | 0.7222 | 72.22% |
P-glycoprotein substrate | + | 0.7333 | 73.33% |
CYP3A4 substrate | + | 0.6332 | 63.32% |
CYP2C9 substrate | + | 0.5942 | 59.42% |
CYP2D6 substrate | - | 0.8313 | 83.13% |
CYP3A4 inhibition | - | 0.8826 | 88.26% |
CYP2C9 inhibition | - | 0.9152 | 91.52% |
CYP2C19 inhibition | - | 0.9097 | 90.97% |
CYP2D6 inhibition | - | 0.9182 | 91.82% |
CYP1A2 inhibition | - | 0.9211 | 92.11% |
CYP2C8 inhibition | - | 0.7479 | 74.79% |
CYP inhibitory promiscuity | - | 0.9833 | 98.33% |
UGT catelyzed | + | 0.6000 | 60.00% |
Carcinogenicity (binary) | - | 0.8900 | 89.00% |
Carcinogenicity (trinary) | Non-required | 0.6101 | 61.01% |
Eye corrosion | - | 0.9695 | 96.95% |
Eye irritation | - | 0.9034 | 90.34% |
Skin irritation | - | 0.8608 | 86.08% |
Skin corrosion | - | 0.9647 | 96.47% |
Ames mutagenesis | - | 0.7300 | 73.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.5384 | 53.84% |
Micronuclear | + | 0.5200 | 52.00% |
Hepatotoxicity | - | 0.6666 | 66.66% |
skin sensitisation | - | 0.9046 | 90.46% |
Respiratory toxicity | + | 0.6889 | 68.89% |
Reproductive toxicity | - | 0.6013 | 60.13% |
Mitochondrial toxicity | - | 0.7000 | 70.00% |
Nephrotoxicity | - | 0.7684 | 76.84% |
Acute Oral Toxicity (c) | III | 0.6709 | 67.09% |
Estrogen receptor binding | + | 0.7786 | 77.86% |
Androgen receptor binding | + | 0.6141 | 61.41% |
Thyroid receptor binding | + | 0.5328 | 53.28% |
Glucocorticoid receptor binding | + | 0.5600 | 56.00% |
Aromatase binding | + | 0.6531 | 65.31% |
PPAR gamma | + | 0.6800 | 68.00% |
Honey bee toxicity | - | 0.8899 | 88.99% |
Biodegradation | - | 0.7750 | 77.50% |
Crustacea aquatic toxicity | - | 0.7000 | 70.00% |
Fish aquatic toxicity | - | 0.6189 | 61.89% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.76% | 83.82% |
CHEMBL236 | P41143 | Delta opioid receptor | 99.38% | 99.35% |
CHEMBL2581 | P07339 | Cathepsin D | 99.14% | 98.95% |
CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.84% | 89.63% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.18% | 90.17% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.91% | 93.56% |
CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.39% | 98.94% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.16% | 97.23% |
CHEMBL237 | P41145 | Kappa opioid receptor | 97.04% | 98.10% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.89% | 100.00% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 96.60% | 96.67% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 96.33% | 98.05% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 96.13% | 90.20% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.69% | 96.09% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.79% | 100.00% |
CHEMBL3176 | O43603 | Galanin receptor 2 | 94.32% | 98.89% |
CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 94.30% | 99.77% |
CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 94.22% | 96.28% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 93.98% | 99.17% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.85% | 96.47% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 93.65% | 93.10% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.41% | 91.11% |
CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 93.38% | 95.71% |
CHEMBL3018 | Q9Y5Y6 | Matriptase | 93.33% | 98.33% |
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 93.27% | 98.33% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.96% | 97.21% |
CHEMBL2885 | P07451 | Carbonic anhydrase III | 91.74% | 87.45% |
CHEMBL2973 | O75116 | Rho-associated protein kinase 2 | 91.55% | 96.73% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 90.81% | 97.29% |
CHEMBL3837 | P07711 | Cathepsin L | 90.54% | 96.61% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 90.28% | 96.00% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.71% | 100.00% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 89.53% | 92.32% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 88.84% | 93.00% |
CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 88.79% | 96.03% |
CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 88.77% | 95.20% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 88.68% | 82.69% |
CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 88.40% | 92.29% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.35% | 88.42% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 85.81% | 94.45% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.46% | 90.71% |
CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 84.95% | 96.67% |
CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 84.79% | 89.33% |
CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 84.55% | 92.80% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 83.76% | 89.50% |
CHEMBL3308 | P55212 | Caspase-6 | 83.73% | 97.56% |
CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 83.71% | 96.95% |
CHEMBL4296013 | Q5VWK5 | Interleukin-23 receptor | 83.54% | 88.00% |
CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 82.98% | 82.86% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 82.40% | 95.50% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 82.35% | 91.19% |
CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.23% | 94.33% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 82.06% | 96.90% |
CHEMBL3776 | Q14790 | Caspase-8 | 81.93% | 97.06% |
CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 81.90% | 98.24% |
CHEMBL3038469 | P24941 | CDK2/Cyclin A | 81.55% | 91.38% |
CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 81.54% | 97.43% |
CHEMBL3234 | P08631 | Tyrosine-protein kinase HCK | 80.75% | 88.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Phytolacca americana |
PubChem | 162980335 |
LOTUS | LTS0053573 |
wikiData | Q104970965 |